|
84 Companies |
|
113 Products |
|
113 Products |
|
110 Mechanisms of Action |
|
3 Trials |
|
2476 News |
|
| «12345678910111213...4950» |
- Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: Cross-section Survey of Mechanical Ventilation and Acute Respiratory Distress Syndrome in China (clinicaltrials.gov) - Dec 6, 2016
P=N/A, N=555, Completed, Sponsor: Southeast University, China
Recruiting --> Completed | N=1000 --> 555 | Initiation date: Jan 2014 --> Jul 2012 | Trial primary completion date: Dec 2014 --> May 2013
- Trial completion: Efficacy of Inhalation Technique Training. (clinicaltrials.gov) - Nov 30, 2016
P=N/A, N=100, Completed, Sponsor: Medical University of Warsaw
Recruiting --> Completed | N=1000 --> 555 | Initiation date: Jan 2014 --> Jul 2012 | Trial primary completion date: Dec 2014 --> May 2013 Active, not recruiting --> Completed
- Enrollment change, Trial withdrawal, Surgery: Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients (clinicaltrials.gov) - Nov 30, 2016
P=N/A, N=0, Withdrawn, Sponsor: University of Michigan
Active, not recruiting --> Completed N=10 --> 0 | Recruiting --> Withdrawn
- acetazolamide / Generic mfg.
Trial completion, Enrollment change: Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing (clinicaltrials.gov) - Nov 29, 2016
P4, N=130, Completed, Sponsor: University of Utah
N=10 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | N=100 --> 130
- Trial completion, Enrollment change, Trial primary completion date: CONFOCAL: Cerebral Oxygenation and Neurological Outcomes FOllowing CriticAL Illness (clinicaltrials.gov) - Nov 28, 2016
P=N/A, N=116, Completed, Sponsor: Queen's University
Recruiting --> Completed | N=100 --> 130 Recruiting --> Completed | N=150 --> 116 | Trial primary completion date: Nov 2017 --> Sep 2016
- Ventolin (albuterol) / GSK
Enrollment closed, Trial primary completion date: Nebulae: Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators During Mechanical Ventilation (clinicaltrials.gov) - Nov 28, 2016
P=N/A, N=950, Active, not recruiting, Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting --> Completed | N=150 --> 116 | Trial primary completion date: Nov 2017 --> Sep 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2016 --> Dec 2016
- || Trial primary completion date, Compliance: Efficacy and Compliance of the Mandibular Advancement Devices ONIRIS® vs. Custom Made Devices (clinicaltrials.gov) - Nov 22, 2016
P=N/A, N=204, Recruiting, Sponsor: ONIRIS
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2016 --> Dec 2016 Trial primary completion date: Sep 2016 --> Dec 2017
- Trial completion, Enrollment change, Trial primary completion date: Role of Placenta Growth Factor in Sickle Acute Chest Syndrome (clinicaltrials.gov) - Nov 15, 2016
P=N/A, N=136, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Trial primary completion date: Sep 2016 --> Dec 2017 Active, not recruiting --> Completed | N=175 --> 136 | Trial primary completion date: Dec 2016 --> Dec 2012
- Trial completion, Enrollment change: Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic Fibrosis (clinicaltrials.gov) - Nov 15, 2016
P=N/A, N=32, Completed, Sponsor: Universidad San Jorge
Active, not recruiting --> Completed | N=175 --> 136 | Trial primary completion date: Dec 2016 --> Dec 2012 Active, not recruiting --> Completed | N=50 --> 32
- ketamine / Generic mfg.
Trial primary completion date: Pain Relief for Submucosal Resection of Nasal Septum in Adults Does Ketamine Have a Pre-Emptive Effect? (clinicaltrials.gov) - Nov 15, 2016
P=N/A, N=50, Recruiting, Sponsor: Western Galilee Hospital-Nahariya
Active, not recruiting --> Completed | N=50 --> 32 Trial primary completion date: Oct 2016 --> Oct 2017
- Trial completion: Effects of Inspiratory Flow Waveforms on Preload (clinicaltrials.gov) - Nov 9, 2016
P=N/A, N=60, Completed, Sponsor: Military Hospital of Tunis
Trial primary completion date: Oct 2016 --> Oct 2017 Recruiting --> Completed
- Trial suspension, Trial primary completion date: The Effect of CRT on the Hypercapnic Ventilatory Response (clinicaltrials.gov) - Nov 9, 2016
P=N/A, N=40, Suspended, Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Recruiting --> Completed Recruiting --> Suspended | Trial primary completion date: Oct 2015 --> Oct 2017
- budesonide inhalation suspension / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial (clinicaltrials.gov) - Nov 8, 2016
P1, N=30, Active, not recruiting, Sponsor: Vanderbilt University
Recruiting --> Suspended | Trial primary completion date: Oct 2015 --> Oct 2017 Recruiting --> Active, not recruiting | N=20 --> 30 | Trial primary completion date: Sep 2016 --> Dec 2016
- Enrollment change, Trial withdrawal, Trial primary completion date: Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading (clinicaltrials.gov) - Nov 7, 2016
P=N/A, N=0, Withdrawn, Sponsor: Massachusetts General Hospital
Recruiting --> Active, not recruiting | N=20 --> 30 | Trial primary completion date: Sep 2016 --> Dec 2016 N=25 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Apr 2016 --> Sep 2016
- dexamethasone injection / Generic mfg.
Trial initiation date: Effect of Intravenous Lidocaine and Dexamethasone Combination on Postoperative Sore Throat, Cough and Hoarseness. (clinicaltrials.gov) - Nov 7, 2016
P4, N=180, Completed, Sponsor: B.P. Koirala Institute of Health Sciences
N=25 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Apr 2016 --> Sep 2016 Initiation date: Apr 2013 --> Dec 2013
- Trial primary completion date: SUPERNOVA: Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS (clinicaltrials.gov) - Nov 4, 2016
P1/2, N=100, Recruiting, Sponsor: European Society of Intensive Care Medicine
Initiation date: Apr 2013 --> Dec 2013 Trial primary completion date: Jun 2016 --> Dec 2016
- Trial suspension, Trial primary completion date: Results of Manual Therapy on Pulmonary Parameters (clinicaltrials.gov) - Nov 4, 2016
P=N/A, N=60, Suspended, Sponsor: Universidad de Granada
Trial primary completion date: Jun 2016 --> Dec 2016 Active, not recruiting --> Suspended | Trial primary completion date: Jan 2016 --> Jan 2017
- Acetavance (acetaminophen) / Mallinckrodt
Enrollment change, Trial withdrawal: Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA (clinicaltrials.gov) - Nov 4, 2016
P4, N=0, Withdrawn, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Suspended | Trial primary completion date: Jan 2016 --> Jan 2017 N=10 --> 0 | Terminated --> Withdrawn
- modafinil / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date: Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill (clinicaltrials.gov) - Nov 4, 2016
P3, N=0, Withdrawn, Sponsor: Brigham and Women's Hospital
N=10 --> 0 | Terminated --> Withdrawn N=30 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jul 2016 --> Jul 2015
- Enrollment closed, Trial primary completion date: Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE) (clinicaltrials.gov) - Nov 2, 2016
P=N/A, N=12000, Active, not recruiting, Sponsor: Mayo Clinic
N=30 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Jul 2016 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2016
- |||| Ventolin (albuterol) / GSK
Biomarker, Trial completion, Enrollment change: Salbutamol, Pharmacogenetics and Breathing Mechanics (clinicaltrials.gov) - Nov 2, 2016
P4, N=94, Completed, Sponsor: University of British Columbia
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Dec 2016 Active, not recruiting --> Completed | N=70 --> 94
- Trial completion, Enrollment change, Trial primary completion date: Hypertension and Sleep Disordered Breathing in Pediatrics (clinicaltrials.gov) - Nov 2, 2016
P=N/A, N=24, Completed, Sponsor: Melodi Pirzada MD
Active, not recruiting --> Completed | N=70 --> 94 Recruiting --> Completed | N=50 --> 24 | Trial primary completion date: Oct 2010 --> Jul 2011
- Trial completion, Enrollment change, Trial primary completion date: Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome (clinicaltrials.gov) - Oct 31, 2016
P=N/A, N=10, Completed, Sponsor: Wake Forest School of Medicine
Recruiting --> Completed | N=50 --> 24 | Trial primary completion date: Oct 2010 --> Jul 2011 Recruiting --> Completed | N=100 --> 10 | Trial primary completion date: Aug 2016 --> Mar 2015
- ||| Enrollment open, Real-world evidence, Real-world: A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD) (clinicaltrials.gov) - Oct 31, 2016
P=N/A, N=700, Recruiting, Sponsor: AstraZeneca
Recruiting --> Completed | N=100 --> 10 | Trial primary completion date: Aug 2016 --> Mar 2015 Not yet recruiting --> Recruiting
- | Trial completion: Familial Aggregation and Natural History of Sleep Apnea (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=726, Completed, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- trazodone ER / Generic mfg.
Trial completion, Enrollment change: The Effects of Trazodone on Sleep Apnea Severity (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=15, Completed, Sponsor: Brigham and Women's Hospital
No longer recruiting --> Completed Recruiting --> Completed | N=40 --> 15
- Trial primary completion date: KVNI: Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=80, Recruiting, Sponsor: Assistance Publique - H
Recruiting --> Completed | N=40 --> 15 Trial primary completion date: May 2016 --> Jan 2017
- Trial completion, Enrollment change, Trial primary completion date: COMMunication and Education for the New CPAP Experience (clinicaltrials.gov) - Oct 25, 2016
P1, N=21, Completed, Sponsor: University of Pittsburgh
Trial primary completion date: May 2016 --> Jan 2017 Recruiting --> Completed | N=60 --> 21 | Trial primary completion date: Jul 2015 --> Jul 2016
- Trial completion: EMI II: Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD (clinicaltrials.gov) - Oct 25, 2016
P=N/A, N=150, Completed, Sponsor: University Hospital, Brest
Recruiting --> Completed | N=60 --> 21 | Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Completed
- Trial primary completion date: Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea (clinicaltrials.gov) - Oct 25, 2016
P=N/A, N=2, Terminated, Sponsor: University of Zurich
Recruiting --> Completed Trial primary completion date: May 2016 --> Jan 2016
- Trial completion, Enrollment change, Trial primary completion date: AIRLESS: Automate Detection of Sleep Apnea by ApneascanTM (clinicaltrials.gov) - Oct 21, 2016
P4, N=41, Completed, Sponsor: University Hospital, Grenoble
Trial primary completion date: May 2016 --> Jan 2016 Recruiting --> Completed | N=160 --> 41 | Trial primary completion date: Oct 2015 --> Oct 2016
- diphenhydramine / Generic mfg.
Enrollment change, Trial withdrawal: Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis (clinicaltrials.gov) - Oct 19, 2016
P3, N=0, Withdrawn, Sponsor: Ache Laboratorios Farmaceuticos S.A.
Recruiting --> Completed | N=160 --> 41 | Trial primary completion date: Oct 2015 --> Oct 2016 N=208 --> 0 | Not yet recruiting --> Withdrawn
- diphenhydramine / Generic mfg.
Enrollment change, Trial withdrawal: Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis (clinicaltrials.gov) - Oct 19, 2016
P3, N=0, Withdrawn, Sponsor: Ache Laboratorios Farmaceuticos S.A.
N=208 --> 0 | Not yet recruiting --> Withdrawn N=962 --> 0 | Not yet recruiting --> Withdrawn
- Enrollment change, Surgery, Bariatric surgery: The Effect of Obstructive Sleep Apnea on Medical Outcomes After Gastric Bypass Surgery (clinicaltrials.gov) - Oct 18, 2016
P1/2, N=0, Withdrawn, Sponsor: Stanford University
N=962 --> 0 | Not yet recruiting --> Withdrawn N=50 --> 0
- Trial completion, Trial primary completion date: TVLOD: Outcome of Laser or Debrider Tonsillotomy Versus Tonsillectomy in Obstructive Sleep Apnea (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=88, Completed, Sponsor: Soroka University Medical Center
N=50 --> 0 Recruiting --> Completed | Trial primary completion date: Jul 2011 --> Jan 2013
- Trial primary completion date: Airway Muscle Training for Obstructive Sleep Apnea (clinicaltrials.gov) - Oct 17, 2016
P=N/A, N=60, Recruiting, Sponsor: University of Florida
Recruiting --> Completed | Trial primary completion date: Jul 2011 --> Jan 2013 Trial primary completion date: Sep 2016 --> Sep 2017
- | Trial completion, Enrollment change, Trial primary completion date: Dyspnea_ILD: Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease (clinicaltrials.gov) - Oct 12, 2016
P=N/A, N=20, Completed, Sponsor: University of British Columbia
Trial primary completion date: Sep 2016 --> Sep 2017 Recruiting --> Completed | N=32 --> 20 | Trial primary completion date: Oct 2016 --> Apr 2016
- Trial primary completion date: PRESH: Prevalence of Hyperventilation Syndrome in Difficult Asthma (clinicaltrials.gov) - Oct 11, 2016
P=N/A, N=150, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed | N=32 --> 20 | Trial primary completion date: Oct 2016 --> Apr 2016 Trial primary completion date: Apr 2016 --> Nov 2016
- Trial completion, Trial primary completion date: APNEE REA: Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain in Potentiel Organ Donors. (clinicaltrials.gov) - Oct 11, 2016
P=N/A, N=208, Completed, Sponsor: Poitiers University Hospital
Trial primary completion date: Apr 2016 --> Nov 2016 Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2015
- Trial completion: Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain Death in Potential Organ Donors (CPAPNEE STUDY) (clinicaltrials.gov) - Oct 11, 2016
P=N/A, N=208, Completed, Sponsor: Poitiers University Hospital
Recruiting --> Completed | Trial primary completion date: Jul 2015 --> Dec 2015 Recruiting --> Completed
- Trial completion: Pathogenesis and Outcomes of Sleep Disordered Breathing in Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Oct 5, 2016
P=N/A, N=52, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed Recruiting --> Completed
- Trial primary completion date: REV 002 Observational Study of the ReVENT Sleep Apnea System: Minimally Invasive Treatment for Obstructive Sleep Apnea (clinicaltrials.gov) - Oct 4, 2016
P=N/A, N=50, Recruiting, Sponsor: Revent Medical International B.V.
Recruiting --> Completed Trial primary completion date: Sep 2017 --> Dec 2017
- Trial completion: Physiological Study of Low-frequency HFO/HFO-TGI and High-frequency HFO (clinicaltrials.gov) - Oct 4, 2016
P1, N=17, Completed, Sponsor: University of Athens
Trial primary completion date: Sep 2017 --> Dec 2017 Recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes (clinicaltrials.gov) - Oct 3, 2016
P=N/A, N=24, Completed, Sponsor: University of Chicago
Recruiting --> Completed Active, not recruiting --> Completed | N=56 --> 24 | Trial primary completion date: Feb 2017 --> Aug 2015
- Trial primary completion date: Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea (clinicaltrials.gov) - Sep 30, 2016
P=N/A, N=80, Recruiting, Sponsor: Queen's University
Active, not recruiting --> Completed | N=56 --> 24 | Trial primary completion date: Feb 2017 --> Aug 2015 Trial primary completion date: Aug 2016 --> Jun 2017
- Phase classification, Enrollment change, Trial primary completion date: SOMMEDREP: Sleep Respiratory Disorders Evaluation in Sickle Cell Disease Children (clinicaltrials.gov) - Sep 29, 2016
P=N/A, N=120, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Aug 2016 --> Jun 2017 Phase classification: P2/3 --> P=N/A | N=280 --> 120 | Trial primary completion date: Mar 2017 --> Aug 2018
- aspirin / Generic mfg.
Trial primary completion date: High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD) (clinicaltrials.gov) - Sep 29, 2016
P=N/A, N=10, Recruiting, Sponsor: Brigham and Women's Hospital
Phase classification: P2/3 --> P=N/A | N=280 --> 120 | Trial primary completion date: Mar 2017 --> Aug 2018 Trial primary completion date: Jul 2016 --> Mar 2017
- Trial termination: OSAVTE: Obstructive Sleep Apnea and Venous Thromboembolism (clinicaltrials.gov) - Sep 28, 2016
P=N/A, N=85, Terminated, Sponsor: University of Missouri-Columbia
Trial primary completion date: Jul 2016 --> Mar 2017 Withdrawn --> Terminated; Investigator left the institution
- Trial completion, Enrollment change, Trial primary completion date: Pathophysiologic Changes in the Respiratory System During Therapeutic Interventions (clinicaltrials.gov) - Sep 27, 2016
P=N/A, N=25, Completed, Sponsor: Oslo University Hospital
Withdrawn --> Terminated; Investigator left the institution Recruiting --> Completed | N=60 --> 25 | Trial primary completion date: Dec 2013 --> May 2016
- Enrollment change, Trial termination, Trial primary completion date: Safety and Performance Study of the Nyxoah SAT System for Treating OSA (clinicaltrials.gov) - Sep 27, 2016
P=N/A, N=6, Terminated, Sponsor: Nyxoah S.A.
Recruiting --> Completed | N=60 --> 25 | Trial primary completion date: Dec 2013 --> May 2016 N=15 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Apr 2016 --> Nov 2015